OUtcome of Cypher stent with patients on Hemodialysis registry

OUtcome of Cypher stent with patients on Hemodialysis registry - OUCH registry

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001155

Enrollment

120

Registered

2008-05-14

Start date

2007-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients who undergo elective percutaneous coronary intervention (PCI) using sirolimus eluting stents

Interventions

Percutaneous coronary intervention (PCI) using sirolimus eluting stents

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic hemodialysis patients. Elective PCI using sirolimus eluting stents.

Exclusion criteria

Exclusion criteria: Peritoneal dialysis. Cardiac arrest or survivor of sudden death. Cardiac shock. Emergent PCI. ST elevation myocardial infarction. Impossible to use antiplatelet drugs. Coronary stent implantation within 6 months. In stent restenosis lesion wihin drug eluting stents. Severe valvular disease. Critical limb ischemia. Chronic total occlusion as a target vessel.

Design outcomes

Primary

Measure	Time frame
Target vessel failure (TVF) including cardiac death, myocardial infarction in the target vessel and target vessel revascularization.	—

Secondary

Measure	Time frame
Binary restenosis rate and late loss. Mortality and major adverse cardiac event rates at 12 months. Intimal hyperplasia measured by IVUS. Relation between dialysis membrane and MACE or lat loss. Relation between alpha 2 macroglobulin and late lumen loss.	—

Countries

Japan

Contacts

Public ContactYuji Ikari

Tokai University Cardiology

ikari@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026